A new type of liposomal liver-specific contrast medium (CM) in CT was studied, and the results were compared with those obtained with Mn-DPDP, a paramagnetic hepatobiliary CM, in MR imaging. The contrasts of normal liver tissue to tumorous tissue and the importance of the CM for tumour detection in the 2 modalities were studied in a rabbit tumour model. CT and T1-weighted pre- and postcontrast and T2-weighted MR images precontrast were obtained.
Material, Methods and Results:
Compared to precontrast images, significantly higher contrasts of normal liver tissue to tumorous tissue were obtained after CM administration in both CT and MR examinations. At radiologic evaluation, significantly more tumours were detected after CM administration in CT and in T1-weighted MR images than in precontrast images in CT and T1-weighted MR. There were no significant differences in tumour detection frequency in MR studies including a T2-weighted pulse sequence, postcontrast CT, or postcontrast T1-weighted MR imaging.
Conclusion:
The use of liver-specific CM improves visualization of liver tumours in CT and T1-weighted MR imaging.
AdzamliI. K.SeltzerS. E.SlifkinM.BlauM.AdamsD. F.: Production and characterization of improved liposomes containing radiographic contrast media. Invest. Radiol.25 (1990), 1217.
2.
BernardinoM. E.YoungS. W.LeeJ. K. T.WeinrebJ. C.: Hepatic MR imaging with Mn-DPDP. Safety, image quality, and sensitivity. Radiology183 (1992), 53.
3.
DwyerA. J.: Matchmaking and McNemar in the comparison of diagnostic modalities. Radiology178 (1991), 328.
4.
ElizondoG.FretzC. J.StarkD. D.: Preclinical evaluation of Mn-DPDP. New paramagnetic hepatobiliary contrast agent for MR imaging. Radiology178 (1991), 73.
5.
FahlvikA. K.HoltzE.LeanderP.SchröderU.KlavenessJ.: Magnetic starch microspheres; efficacy and elimination. A new organ-specific contrast agent for magnetic resonance imaging. Invest. Radiol.25 (1990), 113.
6.
FahlvikA. K.HoltzE.SchröderU.KlavenessJ.: Magnetic starch microspheres; biodistribution and biotransformation. A new organ-specific contrast agent for magnetic resonance imaging. Invest. Radiol.25 (1990), 793.
7.
FerrucciJ. T.StarkD. D.: Iron oxide-enhanced MR imaging of the liver and spleen. Review of the first 5 years. AJR155 (1990), 943.
8.
HammB.VoglT. J.BrandingG.: Focal liver lesions. MR imaging with Mn-DPDP — Initial clinical results in 40 patients. Radiology182 (1992), 167.
9.
HammB.WolfK.FelixR.: Conventional and rapid MR imaging of the liver with gadolinium-DTPA. Radiology164 (1987), 313.
10.
HarnedR. K.ChezmarJ. L.NelsonR. C.: Imaging of patients with potentially resectable hepatic neoplasms. AJR159 (1992), 1191.
11.
IvancevK.LunderquistA.IsakssonA.HochbergsP.WretlindA.: Clinical trials with a new iodinated lipid emulsion for computed tomography of the liver. Acta Radiol.30 (1989), 449.
12.
JanoffA. S.MincheyS. R.PerkinsW. R.: Interdigitation-fusion vesicles. A new approach for selective opacification of the RES. Invest. Radiol.26Suppl. (1991), S167.
13.
LamarqueJ. L.BruelJ. M.DondelingerR.: The use of iodolipids in hepatosplenic computed tomography. J. Comput. Assist. Tomogr.3 (1979), 21.
14.
LeanderP.: A new liposomal contrast medium for CT of the liver. An imaging study in a rabbit tumour model. Acta Radiol.37 (1996), 63.
15.
LeanderP.GolmanK.: MRI liver contrast media in a rabbit liver tumour model (Abstract, p. 1156). Soc. Magn. Reson. Med., 8th Annual Meeting. Amsterdam 1989.
16.
LeanderP.GolmanK.KlavenessJ.HoltzE.OlssonM.LeunbachI.: MRI contrast media for the liver. Efficacy in conditions of acute biliary obstruction. Invest. Radiol.25 (1990), 1130.
17.
LeanderP.GolmanK.StrandeP.KlavenessJ.BesjakovJ.FältK.: A comparison between IEEC, a new biodegradable particulate contrast medium, and iohexol in a tumor model of computed tomography of the liver. Invest. Radiol.28 (1993), 513.
18.
NelsonR. C.ChezmarJ. L.SteinbergH. V.: Focal hepatic lesions. Detection by dynamic and delayed computed tomography versus short TE/TR spin echo and fast field echo magnetic resonance imaging. Gastrointest. Radiol.13 (1988), 115.
PlewesD. B.DeanP. B.: Detectability of spherical objects by computed tomography. Radiology133 (1979), 785.
21.
RocklageS. M.CacherisW. P.QuayS. C.HahnF. E.RaymondK. N.: Manganese(ii) N,N′-dipyridoxylethylenediamine-N,N′-diacetate 5,5′-bis(phosphate). Synthesis and characterisation of a paramagnetic chelate for magnetic resonance imaging enhancement. Inorg. Chem.28 (1989), 477.
22.
RofskyN. M.WeinrebJ. C.: Manganese(ii) N,N′-dipyridoxylethylenediamine-N,N′-diacetate 5,5′-bis(phosphate). Clinical experience with a new contrast agent. Magn. Reson. Q.8 (1992), 156.
23.
RummenyE. J.WerneckeK.SainiS.: Comparison between high-field-strength MR imaging and CT for screening of hepatic metastases. A receiver operating characteristic analysis. Radiology182 (1992), 879.
24.
SachseA.LeikeJ. U.RösslingG. L.WagnerS. E.KrauseW.: Preparation and evaluation of lyophilized iopromide-carrying liposomes for liver tumor detection. Invest. Radiol.28 (1993), 838.
25.
SchwartzL. H.SeltzerS. E.TempanyC. M. C.: Prospective comparison of T2-weighted fast spin-echo, with and without fat suppression, and conventional spin-echo pulse-sequences in the upper abdomen. Radiology189 (1993), 411.
SeltzerS. E.JanoffA. S.BlauM.AdamsD. F.MincheyS. R.BoniL. T.: Biodistribution and imaging characteristics of iotrolan-carrying interdigitation-fusion vesicles. Invest. Radiol.26Suppl. (1991), S169.
28.
SemelkaR. C.ShoenutJ. P.KroekerM. A.: Focal liver disease. Comparison of dynamic contrast-enhanced CT and T2-weighted fat-suppressed, FLASH, and dynamic gadolinium-enhanced MR imaging at 1.5 T. Radiology184 (1992), 687.
29.
StarkD. D.WeisslederR.ElizondoG.: Superparamagnetic iron oxide. Clinical application as a contrast agent for MR imaging of the liver. Radiology168 (1988), 297.
30.
StarkD. D.WittenbergJ.ButchR. J.FerrucciJ. T.: Hepatic metastases. Randomized, controlled comparison of detection with MR imaging and CT. Radiology165 (1987), 399.
31.
VermessM.DoppmanJ. L.SugarbakerP. H.: Computed tomography of the liver and spleen with intravenous lipoid contrast material. Review of 60 examinations. AJR138 (1982), 1063.
32.
ViolanteM. R.DeanP. B.: Improved detectability of VX2 carcinoma in the rabbit liver with contrast enhancement in computed tomography. Radiology134 (1980), 237.
33.
WerneckeK.HenckeL.VasalloP.: Pathologic explanation for hypoechoic halo seen on sonograms of malignant liver tumors. An in vitro correlative study. AJR159 (1992), 1011.
34.
WerneckeK.RummenyE.BongartzG.: Detection of hepatic masses in patients with carcinoma. Comparative sensitivities of sonography, CT, and MR imaging. AJR157 (1991), 731.
